Authors: Rockson, SG Razavi, M Szuba, A Filardo, S Fitzgerald, P Cooke, JP Yousuf, S Kramer, P DeVault, AR Renschler, MF Adelman, DC

Citation: Sg. Rockson et al., Photoangioplasty recount: Clear punch or dimpled chad? Response, CIRCULATION, 104(11), 2001, pp. E55-E56

Authors: Carde, P Timmerman, R Mehta, MP Koprowski, CD Ford, J Tishler, RB Miles, D Miller, RA Renschler, MF

Citation: P. Carde et al., Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases, J CL ONCOL, 19(7), 2000, pp. 2074-2083

Authors: Rockson, SG Kramer, P Razavi, M Szuba, A Filardo, S Fitzgerald, P Cooke, JP Yousuf, S DeVault, AR Renschler, MF Adelman, DC

Citation: Sg. Rockson et al., Photoangioplasty for human peripheral atherosclerosis - Results of a phaseI trial of photodynamic therapy with motexafin lutetium (Antrin), CIRCULATION, 102(19), 2000, pp. 2322-2324

Authors: Rosenthal, DI Nurenberg, P Becerra, CR Frenkel, EP Carbone, DP Lum, BL Miller, R Engel, J Young, S Miles, D Renschler, MF

Citation: Di. Rosenthal et al., A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging, CLIN CANC R, 5(4), 1999, pp. 739-745

Authors: Miller, RA Woodburn, K Fan, Q Renschler, MF Sessler, JL Koutcher, JA

Citation: Ra. Miller et al., In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer, INT J RAD O, 45(4), 1999, pp. 981-989